Introduction 

In early 2021, VCSQI partnered with the Maryland Academic Consortium for Percutaneous Coronary Intervention Appropriateness and Quality (MACPAQ) to enhance the film review process for our members.  This process was trialed with 2 member programs and feedback has been favorable.   

VCSQI is now offering these services to additional member of VCSQI at no additional cost. 

 

The Maryland Academic Consortium for Percutaneous Coronary Intervention Appropriateness and Quality (MACPAQ) is a collaboration between the Divisions of Cardiology at the Johns Hopkins University and the University of Maryland to assure quality of PCI services. The purpose of MACPAQ is to perform ongoing, blinded, independent external peer review that focuses on both quality and appropriateness of services as well as procedural outcomes and the accuracy of reporting procedures. The method of the review is a physician-led, random review of 5% of cases.

 

The goal is to provide objective feedback to hospitals and physicians. MACPAQ’s primary review includes a three-fold review of “appropriateness” of PCI. Appropriateness is evaluated based on the ACC/AHA guidelines, standard clinical practice, and a review of the angiographic stenosis severity. MACPAQ also assesses procedure outcome and quality and the accuracy of reporting. 

MACPAQ Reviewers are independent of Virginia.

Requirements are strict for the reviewers:

  • Board-certified in interventional cardiology,

  • Shall have practiced interventional cardiology, as evidenced by maintenance of hospital privileges and the provision of PCI services to patients, within the five-year period,

  • Shall have a lifetime PCI case volume over 500 cases, excluding cases performed as part of an interventional cardiology fellowship.